Cargando…
1387. Women Living with HIV (WLWH) Lose IFNγ Responses Diagnostic of Latent TB Infection (LTBI) during Pregnancy and after INH Prophylactic Treatment (IPT)
BACKGROUND: TB is the most common opportunistic infection in PLWH. IPT is recommended for PLWH in endemic areas and for those with LTBI diagnosed by Quantiferon gold-in-tube (QGIT) or tuberculin skin test (TST) in other areas. We report on the performance of QGIT and TST in pregnant WLWH who receive...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808683/ http://dx.doi.org/10.1093/ofid/ofz360.1251 |
_version_ | 1783461794750136320 |
---|---|
author | Weinberg, Adriana Aaron, Lisa Montepiedra, Grace Sterling, Timothy Chaktoura, Nahida Browning, Renee Mmbaga, Blandina T Vhembo, Tichaona Nandkumar. Naik, Shilpa Pahwa, Savita Mathad, Jyoti S LaCourse, Sylvia McCarthy, Katie S Bradford, Sarah Costello, Diane G Zimmer, Bonnie Flore Pierre, Marie Gupta, Amita Theron, Gerhard B |
author_facet | Weinberg, Adriana Aaron, Lisa Montepiedra, Grace Sterling, Timothy Chaktoura, Nahida Browning, Renee Mmbaga, Blandina T Vhembo, Tichaona Nandkumar. Naik, Shilpa Pahwa, Savita Mathad, Jyoti S LaCourse, Sylvia McCarthy, Katie S Bradford, Sarah Costello, Diane G Zimmer, Bonnie Flore Pierre, Marie Gupta, Amita Theron, Gerhard B |
author_sort | Weinberg, Adriana |
collection | PubMed |
description | BACKGROUND: TB is the most common opportunistic infection in PLWH. IPT is recommended for PLWH in endemic areas and for those with LTBI diagnosed by Quantiferon gold-in-tube (QGIT) or tuberculin skin test (TST) in other areas. We report on the performance of QGIT and TST in pregnant WLWH who received IPT antepartum (AP) or postpartum (PP). METHODS: WLWH participating in IMPAACT P1078, a randomized, double-blind, placebo-controlled study comparing 28 weeks of IPT AP vs. PP, were tested by QGIT at entry (14–34 weeks gestation) and by QGIT and TST at delivery (L&D) and 44 weeks PP. Serial QGIT positivity was assessed by logistic regression using generalized estimating equations. RESULTS: Among 944 women with study entry mean (SD) of 29 (6) years of age, 521 (245) CD4+ cells/µL, on ART, including 63% with undetectable HIV plasma RNA, 284/944 (30%) were QGIT+ AP, 215/862 (25%) at L&D and 246/764 (32%) PP (P < 0.001), while 127 (15%) were TST+ at L&D and 126 (17%) PP. QGIT was more likely positive than TST at L&D (Odds ratio = 4.3; 95% CI = 2.8–6.8) and PP (6.4; 3.9–10.7; P < 0.001). QGIT and TST agreement coefficients (95% CI) were 0.4 (0.3–0.5) at L&D and 0.5 (0.4–0.5) PP. Among women QGIT+ AP, 59 (24%) reverted to QGIT- or indeterminate at L&D. However, 37 (63%) reverters recovered QGIT+ results PP, suggesting transient suppression of IFNg responses during pregnancy. Responses to the mitogen-positive QGIT kit control were absent in 60 (7%) women AP, 116 (16%) at L&D, but only 3 (0.4%) PP (P < 0.01), supporting the notion of transient immune suppression during pregnancy. Among women QGIT- AP, 33 (7%) converted to QGIT+ PP. Among AP QGIT+ women, 24 (11%) reverted to QGIT- PP after finishing IPT. None of the results differed between treatment arms (P ≥ 0.13). CONCLUSION: In WLWH on ART, the loss of IFNγ responses to TB antigen and mitogen in pregnancy decreased the diagnostic value of QGIT. TST was similar at L&D and PP but was less sensitive than QGIT. QGIT conversions likely resulted from a combination of PP immune reconstitution and new TB infections. QGIT reversions might represent a change in TB-specific immunity in response to IPT. Reversions have been reported in adults without HIV after treatment of active TB. The clinical significance of QGIT reversions in PLWH needs further investigation. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6808683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68086832019-10-28 1387. Women Living with HIV (WLWH) Lose IFNγ Responses Diagnostic of Latent TB Infection (LTBI) during Pregnancy and after INH Prophylactic Treatment (IPT) Weinberg, Adriana Aaron, Lisa Montepiedra, Grace Sterling, Timothy Chaktoura, Nahida Browning, Renee Mmbaga, Blandina T Vhembo, Tichaona Nandkumar. Naik, Shilpa Pahwa, Savita Mathad, Jyoti S LaCourse, Sylvia McCarthy, Katie S Bradford, Sarah Costello, Diane G Zimmer, Bonnie Flore Pierre, Marie Gupta, Amita Theron, Gerhard B Open Forum Infect Dis Abstracts BACKGROUND: TB is the most common opportunistic infection in PLWH. IPT is recommended for PLWH in endemic areas and for those with LTBI diagnosed by Quantiferon gold-in-tube (QGIT) or tuberculin skin test (TST) in other areas. We report on the performance of QGIT and TST in pregnant WLWH who received IPT antepartum (AP) or postpartum (PP). METHODS: WLWH participating in IMPAACT P1078, a randomized, double-blind, placebo-controlled study comparing 28 weeks of IPT AP vs. PP, were tested by QGIT at entry (14–34 weeks gestation) and by QGIT and TST at delivery (L&D) and 44 weeks PP. Serial QGIT positivity was assessed by logistic regression using generalized estimating equations. RESULTS: Among 944 women with study entry mean (SD) of 29 (6) years of age, 521 (245) CD4+ cells/µL, on ART, including 63% with undetectable HIV plasma RNA, 284/944 (30%) were QGIT+ AP, 215/862 (25%) at L&D and 246/764 (32%) PP (P < 0.001), while 127 (15%) were TST+ at L&D and 126 (17%) PP. QGIT was more likely positive than TST at L&D (Odds ratio = 4.3; 95% CI = 2.8–6.8) and PP (6.4; 3.9–10.7; P < 0.001). QGIT and TST agreement coefficients (95% CI) were 0.4 (0.3–0.5) at L&D and 0.5 (0.4–0.5) PP. Among women QGIT+ AP, 59 (24%) reverted to QGIT- or indeterminate at L&D. However, 37 (63%) reverters recovered QGIT+ results PP, suggesting transient suppression of IFNg responses during pregnancy. Responses to the mitogen-positive QGIT kit control were absent in 60 (7%) women AP, 116 (16%) at L&D, but only 3 (0.4%) PP (P < 0.01), supporting the notion of transient immune suppression during pregnancy. Among women QGIT- AP, 33 (7%) converted to QGIT+ PP. Among AP QGIT+ women, 24 (11%) reverted to QGIT- PP after finishing IPT. None of the results differed between treatment arms (P ≥ 0.13). CONCLUSION: In WLWH on ART, the loss of IFNγ responses to TB antigen and mitogen in pregnancy decreased the diagnostic value of QGIT. TST was similar at L&D and PP but was less sensitive than QGIT. QGIT conversions likely resulted from a combination of PP immune reconstitution and new TB infections. QGIT reversions might represent a change in TB-specific immunity in response to IPT. Reversions have been reported in adults without HIV after treatment of active TB. The clinical significance of QGIT reversions in PLWH needs further investigation. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6808683/ http://dx.doi.org/10.1093/ofid/ofz360.1251 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Weinberg, Adriana Aaron, Lisa Montepiedra, Grace Sterling, Timothy Chaktoura, Nahida Browning, Renee Mmbaga, Blandina T Vhembo, Tichaona Nandkumar. Naik, Shilpa Pahwa, Savita Mathad, Jyoti S LaCourse, Sylvia McCarthy, Katie S Bradford, Sarah Costello, Diane G Zimmer, Bonnie Flore Pierre, Marie Gupta, Amita Theron, Gerhard B 1387. Women Living with HIV (WLWH) Lose IFNγ Responses Diagnostic of Latent TB Infection (LTBI) during Pregnancy and after INH Prophylactic Treatment (IPT) |
title | 1387. Women Living with HIV (WLWH) Lose IFNγ Responses Diagnostic of Latent TB Infection (LTBI) during Pregnancy and after INH Prophylactic Treatment (IPT) |
title_full | 1387. Women Living with HIV (WLWH) Lose IFNγ Responses Diagnostic of Latent TB Infection (LTBI) during Pregnancy and after INH Prophylactic Treatment (IPT) |
title_fullStr | 1387. Women Living with HIV (WLWH) Lose IFNγ Responses Diagnostic of Latent TB Infection (LTBI) during Pregnancy and after INH Prophylactic Treatment (IPT) |
title_full_unstemmed | 1387. Women Living with HIV (WLWH) Lose IFNγ Responses Diagnostic of Latent TB Infection (LTBI) during Pregnancy and after INH Prophylactic Treatment (IPT) |
title_short | 1387. Women Living with HIV (WLWH) Lose IFNγ Responses Diagnostic of Latent TB Infection (LTBI) during Pregnancy and after INH Prophylactic Treatment (IPT) |
title_sort | 1387. women living with hiv (wlwh) lose ifnγ responses diagnostic of latent tb infection (ltbi) during pregnancy and after inh prophylactic treatment (ipt) |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808683/ http://dx.doi.org/10.1093/ofid/ofz360.1251 |
work_keys_str_mv | AT weinbergadriana 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT aaronlisa 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT montepiedragrace 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT sterlingtimothy 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT chaktouranahida 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT browningrenee 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT mmbagablandinat 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT vhembotichaona 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT nandkumarnaikshilpa 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT pahwasavita 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT mathadjyotis 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT lacoursesylvia 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT mccarthykaties 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT bradfordsarah 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT costellodianeg 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT zimmerbonnie 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT florepierremarie 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT guptaamita 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt AT therongerhardb 1387womenlivingwithhivwlwhloseifngresponsesdiagnosticoflatenttbinfectionltbiduringpregnancyandafterinhprophylactictreatmentipt |